<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cultured cell lines Yoshida <z:hpo ids='HP_0001541'>ascites</z:hpo> <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, L-1210 mouse <z:hpo ids='HP_0001909'>leukemia</z:hpo>, OAT cell line derived from human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> of the oat cell type, and P3HR-1 cell line derived from Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> have been used for the cell-killing kinetics study of anticancer agents and evaluation of the sensitivity of cells using the soft agar cloning assay method </plain></SENT>
<SENT sid="1" pm="."><plain>It has been found that there are 2 types of actions: 1) Type I (cytocidal and concentration-dependent action) </plain></SENT>
<SENT sid="2" pm="."><plain>The dose survival curves of Type I agents fit the equation log S=log nminuskD (S, surviving fraction; D, concentration of agents; n and k are constant) </plain></SENT>
<SENT sid="3" pm="."><plain>The sensitivity of cells can be expressed by mean lethal dose 90% (MLD90=1/k) </plain></SENT>
<SENT sid="4" pm="."><plain>Four cell lines were compared on this basis, and some problems concerning the chemotherapy of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> are discussed </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="22333">Alkylating agents</z:chebi> and anticancer antibiotics belonged to this group.2) Type II (<z:chebi fb="0" ids="35610">cytostatic</z:chebi> and time-dependent action) </plain></SENT>
<SENT sid="6" pm="."><plain>The dose survival curves fit the Gompertz equation S=exp[(minusbeta/alpha)(1minus e-aD)] (beta, population reduction parameter; alpha, constant) </plain></SENT>
<SENT sid="7" pm="."><plain>The exposure survival curve is negative exponential, indicating that exposure time rather than concentration is the key fo effective cell killing of Type II agents </plain></SENT>
<SENT sid="8" pm="."><plain>Difficulties in expression of sensitivity to Type II agents are discussed </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="35221">Antimetabolites</z:chebi>, <z:chebi fb="0" ids="27288">Vinca alkaloids</z:chebi>, and L-asparaginase belonged to this group </plain></SENT>
<SENT sid="10" pm="."><plain>The cell-killing kinetics of anticancer agents and comparison of the sensitivity of cells may provide some indications not only of optimal dosage schedules but also of a new approach in screening systems for truly effective agents for human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>